Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Ultra–short-wave diathermy shortens the course of moderate and severe COVID-19: a randomized trial

Liangjiang Huang, Qian Li, Shah Zulfiqar Ali Sayed, Nasb Mohammad, Bin Chen, MPhil Ali Iftikhar, Lingfeng Xie, Jifa Hu, Hong Chen
doi: https://doi.org/10.1101/2021.01.28.21250163
Liangjiang Huang
1Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian Li
2Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shah Zulfiqar Ali Sayed
1Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nasb Mohammad
2Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bin Chen
3Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MPhil Ali Iftikhar
4Paraplegic Center, Hayatabad, Peshawar, Pakistan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lingfeng Xie
1Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jifa Hu
5Office of Academic Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Chen
1Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chenhong1129@hotmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Question Is ultra-short-wave diathermy (USWD) safe and effective in coronavirus disease 2019 (COVID-19) ?

Design Single-centre, evaluator-blinded, two-arm, parallel design, randomized controlled clinical trial.

Participants Moderate and severe COVID-19 patients with acute respiratory syndrome.

Intervention USWD for 10 minutes twice daily for 12 consecutive days along with standard medical treatment (USWD group, n = 25), versus standard medical treatment alone (control group, n = 25).

Outcome measures The primary outcomes were the duration of recovery and negative conversion rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on days 7, 14, 21, and 28. Secondary outcomes included clinical status (seven-category ordinal and systemic inflammatory response syndrome (SIRS) scores), computed tomography (CT), routine blood tests, and adverse events.

Results Time to clinical recovery (USWD 36.84±9.93 vs. control 43.56±12.15, P = 0.037) was significantly shortened with a between-group difference of 6.72 days. Clinical status was improved with significant between-group differences on day 28 (SIRS, P = 0.011; seven-category scale, P = 0.003). The rate of RNA negative conversion at days 7 (P = 0.066), 14 (P = 0.239), 21 (P = 0.269), and 28 (P = 0.490) was statistically insignificant. Moreover, insignificant differences were observed in the artificial intelligence-assisted CT analysis. No treatment-associated adverse events or worsening of pulmonary fibrosis were observed.

Conclusion USWD, as adjunctive therapy, shortened the recovery course and improved clinical status of patients with COVID-19 without aggravating pulmonary fibrosis. the findings are limited due to the small sample size and early termination.

Registration ChiCTR2000029972

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ChiCTR2000029972

Funding Statement

The study was funded by the National Key Research and Development program(NO:2020YFC08845600).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

this randomized controlled trial was approved by the ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (certificate of approval number TJ-C20200127)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This single-center, evaluator-blinded, two-arm, parallel design, randomized controlled clinical trial was aimed to evaluate the safety and efficacy of ultra-short-wave diathermy (USWD) in coronavirus disease 2019 (COVID-19). Moderate and severe COVID-19 patients with the acute respiratory syndrome were recruited at the Tongji Hospital, and USWD was administered for 10 minutes twice daily for 12 consecutive days along with standard medical treatment (USWD group, n = 25), versus standard medical treatment alone (control group, n = 25). The analyses indicated significantly reduced time to clinical recovery in patients in the USWD group than those in the control group. Moreover, seven-category ordinal and systemic inflammatory response syndrome scores were improved in the USWD group on day 28 than in the control group. Additionally, no treatment-associated adverse events or worsening of pulmonary fibrosis were observed in the USWD group. We believe that our study makes a significant contribution to the literature because this is the first randomized clinical trial investigating the efficacy of USWD treatment in COVID-19. Furthermore, USWD as an adjunctive therapy shortened the recovery course and improved the clinical status of patients with COVID-19 without significant adverse events, providing an opportunity to improve the condition of patients worldwide. Further, we believe that this paper will be of interest to the readership of your journal because it provides a new aspect for improving the clinical recovery and rehabilitation of patients with COVID-19, and thus, adheres to the Aims and Scope of the journal. Moreover, USWD group showed no change in the negative SARS-CoV-2 conversion rate, suggesting that the therapeutic effect of USWD is independent of the direct antiviral activity. Finally, the promising pilot-study findings, with no adverse events in the patients, warrant further multi-centre, large-cohort trials to confirm the efficacy of USWD in patients with COVID-19.

Data Availability

The trial data could be provided by a reasonable request to the corresponding authors (HC).

http://www.chictr.org.cn/historyversionpuben.aspx?regno=ChiCTR2000029972

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 30, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Ultra–short-wave diathermy shortens the course of moderate and severe COVID-19: a randomized trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Ultra–short-wave diathermy shortens the course of moderate and severe COVID-19: a randomized trial
Liangjiang Huang, Qian Li, Shah Zulfiqar Ali Sayed, Nasb Mohammad, Bin Chen, MPhil Ali Iftikhar, Lingfeng Xie, Jifa Hu, Hong Chen
medRxiv 2021.01.28.21250163; doi: https://doi.org/10.1101/2021.01.28.21250163
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Ultra–short-wave diathermy shortens the course of moderate and severe COVID-19: a randomized trial
Liangjiang Huang, Qian Li, Shah Zulfiqar Ali Sayed, Nasb Mohammad, Bin Chen, MPhil Ali Iftikhar, Lingfeng Xie, Jifa Hu, Hong Chen
medRxiv 2021.01.28.21250163; doi: https://doi.org/10.1101/2021.01.28.21250163

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Rehabilitation Medicine and Physical Therapy
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (90)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5689)
  • Forensic Medicine (3)
  • Gastroenterology (216)
  • Genetic and Genomic Medicine (868)
  • Geriatric Medicine (88)
  • Health Economics (232)
  • Health Informatics (762)
  • Health Policy (392)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6488)
  • Intensive Care and Critical Care Medicine (391)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (850)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (163)
  • Occupational and Environmental Health (262)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (969)
  • Public and Global Health (2231)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (81)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)